These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 16476686)

  • 81. Data Mining Approaches for Assessing Chemical Coexposures Using Consumer Product Purchase Data.
    Tornero-Velez R; Isaacs K; Dionisio K; Prince S; Laws H; Nye M; Price PS; Buckley TJ
    Risk Anal; 2021 Sep; 41(9):1716-1735. PubMed ID: 33331033
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Sustainable Use of Nanomaterials in Textiles and Their Environmental Impact.
    Saleem H; Zaidi SJ
    Materials (Basel); 2020 Nov; 13(22):. PubMed ID: 33203051
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Nanotechnology in Cosmetics and Cosmeceuticals-A Review of Latest Advancements.
    Gupta V; Mohapatra S; Mishra H; Farooq U; Kumar K; Ansari MJ; Aldawsari MF; Alalaiwe AS; Mirza MA; Iqbal Z
    Gels; 2022 Mar; 8(3):. PubMed ID: 35323286
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Nanomaterials in cosmetics--present situation and future].
    Masunaga T
    Yakugaku Zasshi; 2014; 134(1):39-43. PubMed ID: 24389615
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Hazard and risk assessment strategies for nanoparticle exposures: how far have we come in the past 10 years?
    Warheit DB
    F1000Res; 2018; 7():376. PubMed ID: 29636906
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Manufacture and use of nanomaterials: current status in the UK and global trends.
    Aitken RJ; Chaudhry MQ; Boxall AB; Hull M
    Occup Med (Lond); 2006 Aug; 56(5):300-6. PubMed ID: 16868127
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Nanotechnology in the real world: Redeveloping the nanomaterial consumer products inventory.
    Vance ME; Kuiken T; Vejerano EP; McGinnis SP; Hochella MF; Rejeski D; Hull MS
    Beilstein J Nanotechnol; 2015; 6():1769-80. PubMed ID: 26425429
    [TBL] [Abstract][Full Text] [Related]  

  • 88. EPHECT I: European household survey on domestic use of consumer products and development of worst-case scenarios for daily use.
    Dimitroulopoulou C; Lucica E; Johnson A; Ashmore MR; Sakellaris I; Stranger M; Goelen E
    Sci Total Environ; 2015 Dec; 536():880-889. PubMed ID: 26051596
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Molecular mechanism of nanomaterials induced liver injury: A review.
    Das SK; Sen K; Ghosh B; Ghosh N; Sinha K; Sil PC
    World J Hepatol; 2024 Apr; 16(4):566-600. PubMed ID: 38689743
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Recent Interventions for Nanotechnology Based Drug Products: Insights into the Regulatory Aspects.
    Sarwal A; Singh G; Singh K; Garg S
    Curr Pharm Des; 2018; 24(43):5219-5228. PubMed ID: 30652639
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Predicting emerging chemical content in consumer products using machine learning.
    Thornton LL; Carlson DE; Wiesner MR
    Sci Total Environ; 2022 Aug; 834():154849. PubMed ID: 35405240
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Current status and prospects of population exposure assessment of nanomaterials consumer products].
    Zou XX; Zhang B; Liu LH; Wang HJ; Wu JQ; Yang QY; Zhang XJ; Liu ZQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Aug; 54(8):902-907. PubMed ID: 32842322
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Assessing the Thin Regulation of Consumer-Facing Health Technologies.
    Terry NP
    J Law Med Ethics; 2020 Mar; 48(1_suppl):94-102. PubMed ID: 32342747
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Nanoparticles in Construction Materials and Other Applications, and Implications of Nanoparticle Use.
    Mohajerani A; Burnett L; Smith JV; Kurmus H; Milas J; Arulrajah A; Horpibulsuk S; Abdul Kadir A
    Materials (Basel); 2019 Sep; 12(19):. PubMed ID: 31547011
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Safety Aspects of Bio-Based Nanomaterials.
    Catalán J; Norppa H
    Bioengineering (Basel); 2017 Dec; 4(4):. PubMed ID: 29194367
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Perspectives on advancing consumer product exposure models.
    Cowan-Ellsberry C; Zaleski RT; Qian H; Greggs W; Jensen E
    J Expo Sci Environ Epidemiol; 2020 Sep; 30(5):856-865. PubMed ID: 32546825
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Database development in a regulatory agency.
    Bracken MC; Weiss IJ
    J Chem Inf Comput Sci; 1977 Nov; 17(4):202-5. PubMed ID: 591588
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Uncertainty estimation of exposure factors for consumer products based on various sample sizes.
    Ban H; Seo S; Park JY; Won S; Lee K
    Food Chem Toxicol; 2019 Dec; 134():110874. PubMed ID: 31600565
    [TBL] [Abstract][Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.